DecreaseText Size Reset Text Size Increase Text Size
 
resize Print E-mail
Search
News
31/08/2015
International Activity
Since 1984, Lavipharm Group has embarked on an international course. France was the first "stop" followed by the USA. The Group's activities focus on research as well as international marketing.

It is designed on two strategies: the worldwide promotion and marketing of existing pharmaceutical and skincare products developed in its in-house R&D facilities and the application of Lavipharm's innovative technologies for the development of products on behalf of other major pharmaceutical companies worldwide.

The Group collaborates with multinational companies in order to hold a leading position in the international pharmaceutical market with well-known products, developing simultaneously the difficult but essential Research & Development sector. Lavipharm’s international co operations are with 3M, Abbott Laboratories, Crinos, Dava, Ethypharm, Ferrer, GlaxosmithKline, Helsinn, Kullgren Pharma, Mundipharma, Novartis, Paladin, Pfizer, Pohl Boskamp, Sanofi Aventis, Se-Cure Pharmaceuticals, So.Se. Pharm.

Lavipharm’s international presence is in: Albania, Belgium, Canada, China, Cyprus, France, Germany, Greece, Hong-Kong, Italy, Jordan, Kuwait, Lebanon, Libya, Morocco, Martinique, Mauritius, Qatar, South Arabia, South Korea, Spain, Taiwan, Tunisia, U.S.A..
 





Copyright© 2011 Lavipharm. All Rights Reserved | Legal Restrictions & Terms of use | Privacy Policy